Bone Grafts and Substitutes Market Key Arthrex, Baxter International Inc., Integra Life Sciences Holdings Corporation, Johnson & Johnson, Medtronic Plc., Musculoskeletal Transplant Foundation, NuVasive, Stryker Corporation, Wright Medical Group N.V., and

According to a new report published by Allied Market Research, titled, Bone Grafts and Substitutes Market, by Product and Application: Global Opportunity Analysis and Industry Forecast, 2018-2025," the market was valued at $2,690 million in 2017, and is expected to reach $3,912 million by 2025, growing at a CAGR of 4.8% from 2018 to 2025.

Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/1774?utm_source=openpr&utm_medium=Niranjan

Bone grafts are implantable materials that promote bone healing, bone formation, and osseous reconstruction.

Increase in incidence of musculoskeletal conditions, advancements in medical technology leading to a shift from autograft to the allograft, rise in preference for biocompatible bone grafts are the key factors that contribute toward the growth of the global bone grafts and substitutes market. In addition, an increase in cases of lifestyle disorders such as diabetes and obesity add to the risk of developing degenerative joint diseases that further fuels the growth of the market. However, the major restraints of this market are ethical issues related to bone grafting and the high cost of surgeries.

Cell-based matrices (CBM) is projected to grow at the highest CAGR of 6.1% from 2018 to 2025, as these materials serve as a cell-based bone grafts substitutes that use cells to generate tissue alone or in combination with support matrix. In addition, the advantages offered by CBM such as reproducibility and cost-effectiveness have fueled market growth.

Spinal fusion accounted for the major share of the total market in 2017, as bone grafts and their substitutes are widely used in the spine fusion procedures worldwide However, the joint reconstruction segment is poised to grow at the highest CAGR of 6.2% during the forecast period, due to upsurge in the incidence of bone and joint disorders.

Purchase Inquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/1774?utm_source=openpr&utm_medium=Niranjan

Key Findings of the Bone Grafts and Substitutes Market:
Bone graft substitutes segment dominated the overall market with a share of more than half of the overall market in 2017 and is expected to continue to lead during the forecast period.

Asia-Pacific is expected to witness the highest market growth rate, with a CAGR of 7.3% from 2018-2025.

U.S. accounted for more than half of the overall market in 2017, whereas South Korea is expected to register the highest CAGR of 9.7%.

North America held the dominant position in the global market in 2017 and is expected to maintain its lead throughout the analysis period.

This is attributed to the rise in the incidence of spinal fusion & joint reconstruction procedures, sedentary lifestyle contributing to joint disorders in the geriatric & younger population, and favorable reimbursement rates in the region.

The key players profiled in this report include Arthrex, Inc., Baxter International Inc., Integra LifeSciences Holdings Corporation, Johnson & Johnson (DePuy Synthes), Medtronic Plc., Musculoskeletal Transplant Foundation, NuVasive, Inc., Stryker Corporation, Wright Medical Group N.V., and Zimmer Biomet Holdings, Inc.

3: MARKET OVERVIEW

3.1. Market definition and scope

3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. Market share analysis, 2017

3.4. Market dynamics
3.4.1. Drivers

3.4.1.1. Increasing incidences of musculoskeletal conditions
3.4.1.2. Technological advancements in medical devices leading to a shift from autograft to allograft
3.4.1.3. Development of biocompatible synthetic bone grafts
3.4.1.4. Obesity and diabetes to increase the risk of degenerative joint diseases

3.4.2. Restraints

3.4.2.1. The high cost of surgeries
3.4.2.2. Ethical issues related to bone grafting procedures

3.4.3. Opportunities
3.4.3.1. Emerging markets to offer lucrative growth opportunities

3.5. Government Regulations
3.5.1. FDA

3.5.2. Health Canada

3.5.3. CE Mark

3.5.4. Ministry of Health, Labor and Welfare (MHLW)

3.5.5. Therapeutic Goods Administration (TGA)

3.6. Reimbursement Scenario
3.6.1. U.S.
3.6.2. Europe
3.6.3. Asia-Pacific
3.6.4. LAMEA

About Us:-

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact Us:-

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.